Other

Clinical trials

Moderna Clinical trials increased by 130.0% to $46.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 47.7%, from $88.00M to $46.00M. Over 5 years (FY 2020 to FY 2025), Clinical trials shows a downward trend with a -27.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Metric ID: other_accrued_clinical_trials

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$108.00M$166.00M$283.00M$288.00M$324.00M$269.00M$319.00M$263.00M$290.00M$263.00M$175.00M$136.00M$96.00M$51.00M$94.00M$88.00M$38.00M$30.00M$20.00M$46.00M
QoQ Change—+53.7%+70.5%+1.8%+12.5%-17.0%+18.6%-17.6%+10.3%-9.3%-33.5%-22.3%-29.4%-46.9%+84.3%-6.4%-56.8%-21.1%-33.3%+130.0%
YoY Change————+200.0%+62.0%+12.7%-8.7%-10.5%-2.2%-45.1%-48.3%-66.9%-80.6%-46.3%-35.3%-60.4%-41.2%-78.7%-47.7%
Range$20.00M – $324.00M
CAGR-16.4%
Avg YoY Growth-18.6%
Median YoY Growth-43.2%

Frequently Asked Questions

What is Moderna's clinical trials?
Moderna (MRNA) reported clinical trials of $46.00M in Q1 2026.
How has Moderna's clinical trials changed year-over-year?
Moderna's clinical trials decreased by 47.7% year-over-year, from $88.00M to $46.00M.
What is the long-term trend for Moderna's clinical trials?
Over 5 years (2020 to 2025), Moderna's clinical trials has grown at a -27.2% compound annual growth rate (CAGR), from $98.00M to $20.00M.